Wird geladen...
Temozolomide and oral etoposide in children with recurrent malignant brain tumors
Despite advances in the treatment of brain tumors, the prognosis of children with recurrent malignant brain tumors remains poor. Etoposide (VP-16), an inhibitor of nuclear enzyme deoxyribonucleic acid (DNA)-topoisomerase II, has shown activity in brain tumors. Its efficacy appears schedule dependent...
Gespeichert in:
| Veröffentlicht in: | Drugs Context |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioExcel Publishing Ltd
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7271709/ https://ncbi.nlm.nih.gov/pubmed/32547627 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.2020-3-1 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|